GENOMENEXT Trademark

Trademark Overview

On Friday, August 29, 2025, a trademark application was filed for GENOMENEXT with the United States Patent and Trademark Office. The USPTO has given the GENOMENEXT trademark a serial number of 99365956. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, August 29, 2025. This trademark is owned by Ambry Genetics Corporation. The GENOMENEXT trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical screening; Medical testing for diagnostic or treatment purposes; DNA screening for medical purposes
genomenext

General Information

Serial Number99365956
Word MarkGENOMENEXT
Filing DateFriday, August 29, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, August 29, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical screening; Medical testing for diagnostic or treatment purposes; DNA screening for medical purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 29, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmbry Genetics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAliso Viejo, CA 92656

Trademark Events

Event DateEvent Description
Monday, September 1, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 29, 2025APPLICATION FILING RECEIPT MAILED
Friday, August 29, 2025NEW APPLICATION ENTERED

Related Keywords

genomenext medical purposes screening treatment testing diagnostic